메뉴 건너뛰기




Volumn 37, Issue 2, 2012, Pages 89-95

CD8+CD28-lymphocytes in peripheral blood and serum concentrations of soluble interleukin 6 receptor are increased in patients with graves' orbitopathy and correlate with disease activity

Author keywords

CD8+CD28 lymphocyte; Graves' orbitopathy; Soluble interleukin 6 receptor

Indexed keywords

CD28 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 6 RECEPTOR; INTERLEUKIN RECEPTOR; LIOTHYRONINE; SOLUBLE INTERLEUKIN 6 RECEPTOR; THYROTROPIN; THYROXINE; UNCLASSIFIED DRUG;

EID: 84859615840     PISSN: 07435800     EISSN: 15324206     Source Type: Journal    
DOI: 10.3109/07435800.2011.635622     Document Type: Article
Times cited : (34)

References (21)
  • 1
    • 77349104615 scopus 로고    scopus 로고
    • Graves' ophthalmopathy
    • Bahn RS. Graves' ophthalmopathy. N Engl J Med 2010;362(8):726-738.
    • (2010) N Engl J Med , vol.362 , Issue.8 , pp. 726-738
    • Bahn, R.S.1
  • 2
    • 33846060835 scopus 로고    scopus 로고
    • Glycosaminoglycans in the pathogenesis and diagnostics of Graves' ophthalmopathy
    • Daroszewski J, Rybka J, Gamian A. Glycosaminoglycans in the pathogenesis and diagnostics of Graves' ophthalmopathy. Postepy Hig Med Dosw 2006;60:370-378.
    • (2006) Postepy Hig Med Dosw , vol.60 , pp. 370-378
    • Daroszewski, J.1    Rybka, J.2    Gamian, A.3
  • 3
    • 65549134290 scopus 로고    scopus 로고
    • Orbital fibroblasts from patients with thyroid-associated ophthalmopathy overexpress CD40: CD154 hyperinduces IL-6, IL-8, and MCP-1
    • Hwang CJ, Afifiyan N, Sand D, et al. Orbital fibroblasts from patients with thyroid-associated ophthalmopathy overexpress CD40: CD154 hyperinduces IL-6, IL-8, and MCP-1. Invest Ophthalmol Vis Sci 2009;50(5):2262-2268.
    • (2009) Invest Ophthalmol Vis Sci , vol.50 , Issue.5 , pp. 2262-2268
    • Hwang, C.J.1    Afifiyan, N.2    Sand, D.3
  • 4
    • 78650837135 scopus 로고    scopus 로고
    • PGE2 induces IL-6 in orbital fibroblasts through EP2 receptors and increased gene promoter activity: Implications to thyroid-associated ophthalmopathy
    • Raychaudhuri N, Douglas RS, Smith TJ. PGE2 induces IL-6 in orbital fibroblasts through EP2 receptors and increased gene promoter activity: Implications to thyroid-associated ophthalmopathy. PLoS One 2010;5(12):e15296.
    • (2010) PLoS One , vol.5 , Issue.12
    • Raychaudhuri, N.1    Douglas, R.S.2    Smith, T.J.3
  • 5
    • 77951454787 scopus 로고    scopus 로고
    • Immunopathogenesis of thyroid eye disease: Emerging paradigms
    • Naik VM, Naik MN, Goldberg RA, Smith TJ. Immunopathogenesis of thyroid eye disease: Emerging paradigms. Surv Ophthalmol 2010;55(3):215-226.
    • (2010) Surv Ophthalmol , vol.55 , Issue.3 , pp. 215-226
    • Naik, V.M.1    Naik, M.N.2    Goldberg, R.A.3    Smith, T.J.4
  • 6
    • 23244464983 scopus 로고    scopus 로고
    • IL-1β induces IL-6 expression in human orbital fibroblasts: Identification of an anatomic-site specific phenotypic attribute relevant to thyroid-associated ophthalmopathy
    • Chen B, Tsui S, Smith TJ. IL-1ß induces IL-6 expression in human orbital fibroblasts: Identification of an anatomic-site specific phenotypic attribute relevant to thyroid-associated ophthalmopathy. J Immunol 2005;175:1310-1319. (Pubitemid 41095021)
    • (2005) Journal of Immunology , vol.175 , Issue.2 , pp. 1310-1319
    • Chen, B.1    Tsui, S.2    Smith, T.J.3
  • 9
    • 0027417547 scopus 로고
    • Increased and highly stable levels of functional soluble interleukin-6 receptor in sera from patients with monoclonal gammapathy
    • Gaillard JP, Batailie R, Brailly H. Increased and highly stable levels of functional soluble interleukin-6 receptor in sera from patients with monoclonal gammapathy. Eur J Immunol 1993;23:820-825.
    • (1993) Eur J Immunol , vol.23 , pp. 820-825
    • Gaillard, J.P.1    Batailie, R.2    Brailly, H.3
  • 11
    • 0029830133 scopus 로고    scopus 로고
    • Increased serum concentrations of IL-6 and sIL-6 receptor in patients with Graves' disease
    • Salvi M, Girasole G, Pedrazzoni M. Increased serum concentrations of IL-6 and sIL-6 receptor in patients with Graves' disease. J Clin EndocrinolMetabol 1996;81:2976-2984.
    • (1996) J Clin EndocrinolMetabol , vol.81 , pp. 2976-2984
    • Salvi, M.1    Girasole, G.2    Pedrazzoni, M.3
  • 13
    • 0142010674 scopus 로고    scopus 로고
    • - T-cell subset of effector cells in the circulation of patients with head and neck cancer
    • DOI 10.1007/s00262-003-0395-6
    • Tsukishiro T, Donnenberg AD, Whiteside TL. Rapid turnover of CD8+CD28- T-cell subset of effector cells in the circulation of patients with head and neck cancer. Cancer Immunol Immunother 2003;52:599-607. (Pubitemid 37268192)
    • (2003) Cancer Immunology, Immunotherapy , vol.52 , Issue.10 , pp. 599-607
    • Tsukishiro, T.1    Donnenberg, A.D.2    Whiteside, T.L.3
  • 14
    • 70350769380 scopus 로고    scopus 로고
    • Increased percentage of CD8+CD28-suppressor lymphocytes in peripheral blood and skin infiltrates correlates with advanced disease with cutaneous T-cell lymphomas
    • Urbaniak-Kujda D, Kapelko-Slowik K,WolowiecD, et al. Increased percentage of CD8+CD28-suppressor lymphocytes in peripheral blood and skin infiltrates correlates with advanced disease with cutaneous T-cell lymphomas. Postepy Hig Med Dosw, 2009;63:355-359.
    • (2009) Postepy Hig Med Dosw , vol.63 , pp. 355-359
    • Urbaniak-Kujda, D.1    Kapelko-Slowik, K.2    Wolowiec, D.3
  • 15
    • 51349141185 scopus 로고    scopus 로고
    • Association ofGraves' disease and prevalence of circulating IFN-gamma producing CD28- T cells
    • Sun Z, Zhong W, Lu X, et al. Association ofGraves' disease and prevalence of circulating IFN-gamma producing CD28- T cells. J Clin Immunol 2008;28:464-472.
    • (2008) J Clin Immunol , vol.28 , pp. 464-472
    • Sun, Z.1    Zhong, W.2    Lu, X.3
  • 16
    • 0030872679 scopus 로고    scopus 로고
    • Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy
    • Mourits MP, Prummel MF, Wiersinga WM, Koornneef L. Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy. Clin Endocrinol 1997;47(1):9-14, Erratum in: Clin Endocrinol 1997;47(5):632. (Pubitemid 27313981)
    • (1997) Clinical Endocrinology , vol.47 , Issue.1 , pp. 9-14
    • Mourits, M.Ph.1    Prummel, M.F.2    Wiersinga, W.M.3    Koornneef, L.4
  • 19
    • 18744422561 scopus 로고    scopus 로고
    • Proliferation and apoptosis of human CD8+CD28+ and CD8+CD28- lymphocytes during aging
    • Brzezínska A, Magalska A, Szybínska A, Sikora E. Proliferation and apoptosis of human CD8+CD28+ and CD8+CD28- lymphocytes during aging. Exp Gerontol 2004;39:539-544.
    • (2004) Exp Gerontol , vol.39 , pp. 539-544
    • Brzezínska, A.1    Magalska, A.2    Szybínska, A.3    Sikora, E.4
  • 20
    • 77949266099 scopus 로고    scopus 로고
    • CD8+CD28- cells and CD4+CD25+ regulatory T cells in the peripheral blood of advanced stage lung cancer patients
    • Karagǒz B, Bilgi O, Gumus M, et al. CD8+CD28- cells and CD4+CD25+ regulatory T cells in the peripheral blood of advanced stage lung cancer patients. Med Oncol 2010;27(1):29-33.
    • (2010) Med Oncol , vol.27 , Issue.1 , pp. 29-33
    • Karagǒz, B.1    Bilgi, O.2    Gumus, M.3
  • 21
    • 48249136613 scopus 로고    scopus 로고
    • CD8+CD28- suppressive T cells in systemic lupus erythematosus
    • Tulunay A, Yavuz S, Direskeneli H, Eksioglu-Demiralp E. CD8+CD28- suppressive T cells in systemic lupus erythematosus. Lupus 2008;17:630-637.
    • (2008) Lupus , vol.17 , pp. 630-637
    • Tulunay, A.1    Yavuz, S.2    Direskeneli, H.3    Eksioglu-Demiralp, E.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.